(Q40829590)

24 September 2017

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem (English)

1 reference

24 September 2017

0 references

Pseudomonas cepacia

1 reference

Isles A

1

1 reference

24 September 2017

Maclusky I

2

1 reference

24 September 2017

Corey M

3

1 reference

24 September 2017

Gold R

4

1 reference

24 September 2017

Prober C

5

1 reference

24 September 2017

Fleming P

6

1 reference

24 September 2017

Levison H

7

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 1984

1 reference

The Journal of Pediatrics

24 September 2017

1 reference

24 September 2017

104

1 reference

24 September 2017

206-210

1 reference

24 September 2017

2

1 reference

Colonization and. Infection with Pseudomonas cepacia

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Activity of ceftazidime against Pseudomonas aeruginosa from bacteraemic and fibrocystic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Antibiotic treatment of cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Haemophilus infections in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Interaction of purulent material with antibiotics used to treat Pseudomonas infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980993-2

10.1016/S0022-3476(84)80993-2

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference